26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
President Trump has signed into law the Further Consolidated Appropriations Act of 2020. The act con...
Read More >
I blogged last week about the back and forth on the new USDOL proposed salary threshold for exempt s...
Read More >
Many companies that operate their businesses on an independent contractor model or supplement their ...
Read More >
We’ve noted many times that while employees prevail on most motions for conditional certification u...
Read More >
The Massachusetts Superior Court’s recent decision in Burke v. The General Hospital Corp. et. al., ...
Read More >
Earlier this summer the New York State Senate and Assembly passed a bill aimed to amend the New York...
Read More >